Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024, at 9:45 am PT.
Related news for (TNYA)
- Today’s Top Performers: MoBot’s Market Review 08/18/25 12:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/18/25 11:00 AM
- Breaking News: MoBot’s Latest Update as of 08/15/25 04:00 PM
- MoBot alert highlights: NASDAQ: INVZ, NASDAQ: TNYA, NASDAQ: RUN, NASDAQ: CASI, NYSE: UP (08/15/25 03:00 PM)
- Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting
